0897.HK HKSE
Wai Yuen Tong Medicine Holdings Limited
1W: +1.4%
1M: +22.9%
3M: +38.9%
YTD: +1.4%
1Y: +15.4%
3Y: +33.7%
5Y: +108.1%
HK$0.38 ($0.05)
+0.01 (+1.35%)
Weekly Expected Move ±7.4%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$102M
-46.6% ▼
5Y CAGR: +62.0%
Capital Expenditures
$27M
+21.6% ▲
5Y CAGR: +31.9%
Free Cash Flow
$75M
-52.1% ▼
5Y CAGR: +99.6%
Dividends Paid
$199M
+0.0% ▲
Buybacks
$12M
+19.9% ▲
Net Change in Cash
-$23M
+93.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$376M | -$109M | -$21M | $50M | $4M |
| Depreciation & Amort. | $93M | $108M | $113M | $111M | $90M |
| Stock-Based Comp. | $0 | $1M | $5M | $4M | $0 |
| Change in Working Capital | $300M | -$75M | -$33M | -$87M | $27M |
| Other Non-Cash Items | $342M | $107M | $180M | $114M | -$20M |
| Operating Cash Flow | $358M | $116M | $92M | $192M | $102M |
| — Investing Activities — | |||||
| Capital Expenditures | -$60M | -$26M | -$33M | -$35M | -$27M |
| Acquisitions (Net) | $4M | $883K | $49M | -$151M | $0 |
| Investment Purchases | -$134M | -$149M | -$115M | -$41M | $0 |
| Investment Sales | $112M | $162M | $113M | $110M | $42M |
| Other Investing | -$4M | -$3M | $2M | $32M | $266M |
| Investing Cash Flow | -$82M | -$16M | $15M | -$85M | $281M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$204M | -$25M | $6M | -$233M | -$118M |
| Stock Repurchased | $0 | $0 | -$10M | -$15M | -$12M |
| Dividends Paid | $0 | $0 | $0 | $0 | -$199M |
| Other Financing | -$147M | -$179M | -$63M | -$222M | -$77M |
| Financing Cash Flow | -$266M | -$115M | -$67M | -$470M | -$406M |
| Net Change in Cash | $46M | $19M | $23M | -$372M | -$23M |
| Cash End of Period | $530M | $549M | $572M | $155M | $132M |
| Free Cash Flow | $299M | $90M | $58M | $157M | $75M |